Excess levels of insulin relative to glucose in the blood, or hyperinsulinemia, is 29 considered to be a poor prognostic indicator for patients with triple negative breast 30 cancer (TNBC). While this association has been recognized for some time, the 31 mechanistic role of hyperinsulinemia in promoting TNBC remains unclear. We show that 32 insulin treatment leads to genome-wide increase in histone acetylation, in particular at 33 H3K9, through the PI3K/AKT/mTOR pathway in MDA-MB-231 cells. Genome-wide 34 analysis showed that the increase in histone acetylation occurs primarily at gene 35 promoters. In addition, insulin induces higher levels of reactive oxygen species and 36 DNA damage foci in cells. In vivo, hyperinsulinemia also enhances growth of MDA-MB-37 231 derived tumors through increased histone acetylation. These results demonstrate 38 the impact of hyperinsulinemia on altered gene regulation through chromatin and the 39 importance of targeting hyperinsulinemia-induced processes that lead to chromatin 40 dysfunction in TNBC. 41
Introduction 43
Triple negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer 44 that does not express estrogen receptor (ER), progesterone receptor (PR) or human 45 epidermal growth factor receptor 2 (HER2) (Carey, Winer, Viale, Cameron, & Gianni, 46 2010). Recent epidemiological studies suggest that metabolic syndrome and associated 47 disorders are additional risk factors for developing TNBC in premenopausal women 48 (Pierobon & Frankenfeld, 2013) . Multiple factors common to metabolic syndrome, 49 including hyperinsulinemia, hyperglycemia, hyperlipidemia, altered adiponectin and 50 leptin levels can contribute to promote tumor growth and progression (Hursting et al., 51 2012 ). However, it has been shown that hyperinsulinemia alone even in the absence of 52 obesity and T2D is also associated with increased breast cancer incidence (Del Giudice insulin signaling in breast cancer, the mechanistic details of these cellular processes in 89 promoting TNBCs is lacking. Most importantly, the effect of hyperinsulinemia on 90 chromatin and gene expression in the nucleus is unclear. 91
We report here an investigation into the impact of hyperinsulinemia on chromatin 92 acetylation by profiling histone H3 acetylation at lysine 9 (H3K9ac) after insulin 93 treatment of the triple negative breast cancer cell line MDA-MB-231. We show that 94 insulin induces global increases in histone acetylation through the PI3K/AKT/mTOR 95 pathway. We used quantitative ChIP-seq analyses (ChIP-Rx) to show that gene 96 promoters exhibit the greatest increases in histone acetylation. In addition, insulin 97 induces DNA damage in cells through enhanced reactive oxygen species (ROS) 98 production and increased chromatin accessibility. Moreover, increased insulin levels 99 enhance growth of MDA-MB-231 xenograft tumors through enhanced histone 100 acetylation. These findings suggest that hyperinsulinemia leads to altered cell 101 metabolism that influences chromatin acetylation in tumor cells, thereby influencing 102 gene expression across the genome. 103 104 Results 105
Insulin induces genome-wide histone acetylation in MDA-MB-231 cells. 106
To investigate the effect of insulin on chromatin, we treated MDA-MB-231 cells with 107 100nM insulin for different durations and assayed the levels of histone acetylation via 108 western blot. We observed an increase in total histone H3 acetylation levels (acH3) 109 after 3h of insulin treatment ( Figure 1A ). This increase was more pronounced for 110 specific residues such as H3K9 and H3K14 ( Figure 1A ). To confirm that the PI3K-AKT 111 pathway was activated by insulin, we further probed the blots with phospho-AKT 112 antibody. Phospho-AKT levels were induced at higher levels after 1h of insulin 113 treatment, after which the signal was attenuated, as expected ( Figure 1A ). To assess 114 the role of PI3K-AKT/mTOR pathway activation in increasing histone acetylation levels, 115
we used inhibitors targeting mTOR and PI3K kinases. We pre-treated MDA-MB-231 116 cells with mTOR inhibitor rapamycin and PI3K inhibitor LY294002 followed by insulin 117 treatment. Insulin induced phosphorylation of AKT and p70 S6 kinase (S6K), an mTOR 118 kinase substrate, in rapamycin untreated cells ( Figure 1B, lanes 1 and 2) . Rapamycin 119 pre-treatment, however, inhibited the phosphorylation of S6K without affecting AKT 120 phosphorylation confirming that rapamycin indeed inhibited mTOR kinase activity 121 ( Figure 1B, lanes 3 and 4) . Both mTOR inhibition and PI3K inhibition, by rapamycin and 122 LY294002 treatment respectively, inhibited the H3K9ac increase induced by insulin 123 ( Figure 1B and 1C ). To confirm that the insulin induced histone H3 acetylation is 124 chromatin-bound and not on newly synthesized or free histones, we performed 125 chromatin fractionation after insulin treatment followed by western blot analyses. 126
Results showed that insulin induced H3K9ac was exclusively chromatin bound ( Figure  127 S1A-B). 128 mTOR complex 1 (mTORC1) enhances mitochondrial biogenesis and activity by 129 promoting translation of nuclear encoded mitochondrial mRNAs including the 130 components of Complex V and TFAM (transcription factor A, mitochondrial) (Morita et 131 al., 2013) . To test whether insulin induced histone acetylation increase was correlated 132 with enhanced mitochondrial activity, we performed western blot analyses for TFAM and 133 ATP5D (a subunit of the ATP synthase complex/Complex V) after insulin treatment. 134 TFAM and ATP5D protein levels increase after 1h insulin treatment ( Figure 1D ). Next, 135
we tested indicators of mitochondrial biogenesis and activity after insulin treatment. 136
Mitochondrial DNA content is an indicator of mitochondrial number and ATP levels are a 137 measure of mitochondrial activity in cells (Morita et al., 2013) . Insulin increased the 138 mitochondrial DNA content ( Figure 1E ) as well as ATP levels ( Figure 1F ) in MDA-MB-139 231 cells, indicating an enhancement in mitochondrial biogenesis and activity. In 140 addition, we performed GC-MS to measure TCA cycle metabolites produced in the 141 mitochondria. We observed increased levels of lactate and TCA cycle intermediates 142 succinate, pyruvate, alpha-ketoglutarate, malate and citrate after 6h of insulin treatment 143 ( Figure S1C ). These data suggest that insulin induces genome-wide increase in histone 144 acetylation, in particular H3K9ac, through the PI3K-AKT-mTOR pathway. 145
Insulin induces H3K9ac acetylation on promoter regions. 146
To characterize the genomic loci associated with increased histone acetylation after 147 insulin treatment, we performed quantitative ChIP-seq analyses as described in 148 (Orlando et al., 2014) where we spiked in Drosophila S2 cells with MDA-MB-231 cells 149 before the chromatin immunoprecipitation (ChIP) (see Methods). We observed an 150 increase in the number of reads aligning to the human genome in the 3h and 6h insulin 151 treated H3K9ac ChIPs indicating an increase in global histone acetylation levels ( Table  152 S1). By performing spike normalization (see Methods, Figure S2A -F), we observed 153 global increases in H3K9ac levels on peaks in 3h and 6h insulin treated cells ( Figure  154 S2A-F). 155
Next, we annotated the H3K9ac peaks based on distance to the nearest RefSeq 156 annotated TSS. Results showed that ~46% of the H3K9ac peaks were promoter 157 proximal (~26% within 1kb and ~20% between 1kb-10kb of nearest TSS) ( Figure 2A ). 158
We used DESeq2 (Love, Huber, & Anders, 2014) to identify peaks that were 159 significantly increased (adjusted P<0.05) in both 3h and 6h insulin treated cells 160 compared to UT. 22,372 and 9,171 peaks were significantly enriched with H3K9ac in 3h 161 and 6h insulin treated cells respectively ( Figure 2B and C). Of the significantly enriched 162 peaks, about 58% and 55% of the peaks were promoter proximal (Figure 2A ) in 3h and 163 6h samples respectively indicating that increases in H3K9ac were majorly localized at 164 promoter regions and could potentially influence gene expression. Heat maps of 165
H3K9ac at ±2kb around annotated start sites of transcripts further confirmed the 166 increase in H3K9ac signal at promoter regions in insulin treated cells. There was a 167 higher enrichment of H3K9ac signals at promoters in 3h compared to 6h treated cells 168 ( Figure S3 ). The highly enriched H3K9ac peaks had significant increases in H3K9ac 169 signal at promoter regions (± 1kb from TSS) of their nearest genes ( Figure 2D and E). 170
These results show that insulin induces genome-wide increase in H3K9ac at promoter 171 regions of genes and thereby could be involved in transcriptional regulation. 172
Insulin induces H3K9ac acetylation on promoters of insulin-induced genes. 173
To further test whether the increase in H3K9ac enrichment levels correlate with gene 174 expression changes induced by insulin, we performed RNA-sequencing (RNA-seq) in 175 MDA-MB-231 cells untreated (UT) or treated for 3h and 6h with insulin. We quantified 176 changes in gene expression after 3h and 6h insulin treatment from RNA-seq data using 177
DESeq2 (Love et al., 2014) . 207 and 384 genes exhibited significantly altered 178 expression in in 3h and 6h insulin treated cells respectively ( Figure 3A and 3B). Insulin 179 treatment induced metabolic pathways required for cellular growth such as ribosome 180 biogenesis, transcription, and splicing as well as known insulin regulated downstream 181 pathways related to ATP production and mTOR signaling ( Figure 3C ). Insulin treatment 182 downregulated FOXO signaling genes as well as apoptosis inducing genes. 183
Interestingly, insulin treatment also downregulated genes involved in reactive oxygen 184 species (ROS) metabolism or scavenging as well as immune cell migration and 185 activation. Moreover, insulin upregulated several MYC (c-Myc) target genes and genes 186 related to zinc ion homeostasis in cells ( Figure 3C ). These results indicate that insulin 187 induces cell growth and proliferation while also suppressing apoptosis. 188
We then compared the changes in H3K9ac enrichment on the promoter regions (TSS 189 ±1kb) of genes upregulated and downregulated by insulin. Upregulated genes showed a 190 larger increase in H3K9ac enrichment induced by insulin ( Figure 3E and 3G) at 3h and 191 6h respectively. However, genes downregulated at 3h also showed a modest but 192 significant increase in H3K9ac enrichment at their promoters ( Figure 3F ). Interestingly, 193 genes downregulated after 6h insulin treatment did not show any significant enrichment 194 in H3K9ac signals ( Figure 3H ). These results indicate that there is a genome-wide 195 increase in H3K9ac signal at all expressed genes after 3h insulin treatment. However, 196 at 6h the increase in H3K9ac signal is more specific to upregulated genes. In order to further characterize the signal-dependent transcription factors involved in the 208 altered gene expression network as well as chromatin acetylation induced by insulin, we 209 performed transcription factor binding motif enrichment analyses. Genes upregulated by 210 insulin showed a significant enrichment of E-box elements that are bound by 211 transcription factors such as MYC (c-Myc), CLOCK, USF1, and BHLHE40 ( Figure 4A) . 212
In addition to E-box elements, binding motifs for NRF1, ELF1, ELK1 and E2F 213 transcription factors were also enriched. Interestingly, MYC target genes were also 214 enriched in the upregulated gene set ( Figure 3C ), further implicating the involvement of 215 MYC in enhancing expression of genes in response to insulin. Moreover, PI3K/AKT and 216 MAPK pathways induced by insulin are known to enhance MYC activity by promoting 217 the degradation of MAD1, an antagonist of MYC (Zhu, Blenis, & Yuan, 2008) . We then 218 categorized peaks with significantly increased H3K9ac signals based on distance from 219 TSS of known RefSeq genes. We defined proximal peaks as peaks within 10kb of a 220 known TSS and distal peaks as those outside this window. Proximal peaks with 221 increased H3K9ac signals showed enrichment of transcription factor binding motifs for 222 SP1, NRF1, ATF3, ELK1 and AP1 transcription factors among others ( Figure 4B ). Distal 223 peaks that exhibited increased H3K9ac signal in response to insulin showed enrichment 224 of FOS, JUN and AP1 family transcription factor binding sites ( Figure 4C ). NRF1 225 (Nuclear Respiratory factor 1) is required for expression of key metabolic genes 226 regulating cellular growth. NRF1 also regulates the expression of several nuclear-227 encoded mitochondrial genes (Witkiewicz et al., 2011) . As we earlier observed 228 increased protein levels of mitochondrial proteins TFAM and ATP5D in response to 229 insulin ( Figure 1D ), we tested whether NRF1 enrichment at its binding sites were 230 enhanced after insulin treatment. ChIP experiments showed that NRF1 binding indeed 231 increased after 3h insulin treatment at promoters of upregulated genes ( Figure 4D -K). 232
Increased NRF1 binding was also observed 6h post-insulin treatment, however, it was 233 lower than that at 3h ( Figure 4D -K) indicating an early response to insulin. NRF1 234 binding at promoters of NRF1 target genes could lead to increased histone acetylation 235 at these regions. These results indicate that NRF1 might regulate the metabolic 236 capacity of cancer cells by integrating metabolic inputs from the environment to 237 increase histone acetylation on chromatin that allow continuous transcription from these 238
genes. 239

Insulin induced reactive oxygen species (ROS) causes genome instability. 240
mTOR pathway induces mitochondrial biogenesis and activity that might lead to 241 increased ROS production through the electron transport chain. To investigate whether 242 insulin treatment induces ROS production in the cells, we measured ROS using a 243 fluorescent dye, CellROX green. Results showed that ROS was significantly increased 244 after 3h of insulin treatment and remained high at 6h ( Figure 5A ). Increase in ROS 245 production could be deleterious to cells as the free radicals could cause DNA damage 246 and mutation. We measured DNA damage using the DNA damage marker g-H2AX in 247 cells treated with insulin using immunofluorescence assays. We observed that the 248 number of cells with g-H2AX foci and the number of g-H2AX foci per cell increased after 249 3h insulin treatment ( Figure 5B ). Interestingly, the number of cells with g-H2AX foci 250 decreased after 6h indicating possible activation of repair pathways ( Figure 5B To investigate whether insulin induced chromatin changes can be reversed, we used 258 metformin, a drug that is used for treatment of pre-diabetes and diabetes (Hostalek, showed enhanced expression of genes related to collagen biosynthesis, extracellular 289 matrix organization, cellular chemotaxis and interferon signaling ( Figure 6D ). Moreover, 290
tumors grown under hyperinsulinemia showed decreased expression of FAS signaling, 291 cell cycle and DNA damage checkpoint genes as well as genes that negatively regulate 292 autophagy and PI3K-AKT signaling ( Figure 6E ). We also validated a few upregulated 293 and downregulated genes from more tumors from each group by RT-qPCR to confirm 294 the RNA-seq results ( Figure 6F -I). 295
The gene expression changes induced by insulin in MDA-MB-231 cells cultured in vitro 296
were not exactly mirrored by the gene expression changes in tumor xenografts in 297 hyperinsulinemic mice. This observation is likely due to the fact that the MDA-MB-231 298 cells grown in vitro showed very different gene expression profiles as compared to the 299 MDA-MB-231 tumors grown in Rag/WT mice. This is consistent with previous results 300 demonstrating that breast cancer cells grown in a monolayer behave differently than 301 those grown in a 3D microenvironment (Edmondson, Broglie, Adcock, & Yang, 2014) . 302
Moreover, the insulin treatment performed in vitro is a short (3h-6h) and acute (100 nM) 303 exposure to insulin whereas tumors from Rag/MKR mice are exposed to chronic 304 Metabolic syndrome and its associated disorders are increasingly being recognized as 311 enhanced risk factors for several types of cancers, including breast cancer. We 312 investigated the impact of hyperinsulinemia, an important feature of metabolic 313 syndrome, on chromatin and gene expression changes in TNBC cells. We observed 314 genome-wide increases in chromatin-associated histone acetylation that was dependent 315 on the insulin mediated signaling through the PI3K-AKT-mTOR pathway. We used a 316 quantitative method of ChIP-seq (ChIP-Rx) to identify the regions associated with 317 changes in H3K9ac in response to insulin. We found genome-wide increases in H3K9ac 318 occupancy at gene promoters especially those that increased expression after insulin 319 treatment. However, insulin-induced increase in histone acetylation at gene promoters 320 was not always associated with an increase in gene expression indicating that 321 increased acetylation at these sites may have a distinct function. Our observation is 322
supported by a recent study investigating histone acetylation levels in response to high 323 glucose levels (Lee et al., 2018) . Interestingly, it has been proposed that histone 324 acetylation may function as a capacitor for acetate/acetyl-CoA which could be utilized 325 as an energy source or to balance the intracellular pH based on cellular condition 326 (Kurdistani, 2014) . 327
Insulin has long been proposed to be involved in breast tumor progression. Fifty Thermofisher Scientific). 409
Mitochondrial DNA and ATP measurement 410
For mitochondrial DNA quantification, genomic DNA and mitochondrial DNA was 411 extracted from insulin treated cells using DNeasy Blood and Tissue kit (Qiagen, Hilden, 412 Germany). Genomic and mitochondrial DNA were quantified by qPCR using 413 mitochondrial and genomic DNA specific primers; namely, cytochrome B and RPL13A 414 (Table S2) . 415
For ATP measurement, MDA-MB-231 cells untreated or treated with insulin in 12 well 416 plates were lysed by boiling in deionized water for 5 mins. The lysate was clarified by 417 centrifugation at 16000´g for 10mins at 4°C. ATP levels were measured using the 418 luciferase-based ATP determination kit (Cat No. A22066; Thermofisher Scientific). 
Chromatin fractionation 428
Chromatin fractionation was performed using the method described in (Mendez & 429 Stillman, 2000) . Briefly, cells were collected from six well plates after insulin treatment 
Immunofluorescence analyses 442
MDA-MB-231 cells were grown on cover slips coated with poly-L-lysine at 37°C in a 5% 443 CO 2 incubator. After treatment, the DMEM medium was aspirated out and the cell layer 444 was washed twice with PBS. The cells were fixed with 4% para-formaldehyde in PBS 445 for 10 mins at RT. The para-formaldehyde solution was removed and quenched with 446 100mM Tris pH 7.2 for 5 mins at RT. The fixed cells were subsequently permeabilized 447 by incubating in 0.1% Triton X-100 solution in PBS for 10 mins. The cells were then 448 washed twice with PBS at 5 mins intervals and blocked using the blocking solution (10% 449 FBS, 3% BSA in PBS containing 0.1% Triton X-100), for 45 mins at 37°C. After ThermoFisher Scientific) for 30 mins in culture medium at 37°C. Subsequently, the 459 culture medium was aspirated and cells were washed thrice with PBS. Nuclei were 460 stained using 10 µg/ml DAPI solution (Cat No. D1306; ThermoFisher Scientific) for 5 461 mins in the dark, followed by two washes with PBS. The coverslips were then inverted 462 onto a microscopic slide over a drop of 70% Glycerol (in PBS) for visualization. The 463
Alexa, DAPI and CellROX Green fluorescence were visualized with a Carl Zeiss 464 confocal laser scanning microscope LSM 710 META. Images were captured using Zen 465 software. ImageJ software was used to process the images. The images for 466 comparative studies were captured at identical microscope settings. 467
ChIP-Rx 468
ChIP-Rx was performed as described in (Orlando et al., 2014) with minor modifications. 469 MDA-MB-231 cells were seeded at a density of 1 ´10 6 cells in 60mm dishes and treated 470 with 100nM insulin as described above. After treatment, cells were cross-linked using 471 1% formaldehyde for 10 mins at RT, followed by addition of 0.125 M glycine for 5 mins 472 to stop the reaction. In parallel, S2 cells were crosslinked at a density of 1 ´10 6 cells per 473 ml using 1% formaldehyde. Crosslinked cells were then washed twice with ice-cold PBS 474 
ChIP-seq analyses 515
Sequencing reads from each library were aligned to a combined reference genome 516 (human + Drosophila) using bowtie (Langmead, Trapnell, Pop, & Salzberg, 2009 ). The 517 combined reference genome was generated as described in (Orlando et al., 2014) . 518
Briefly, a combined genome sequence was created by concatenating the genome 519 sequences of human (hg19) and Drosophila (dm3). Next, custom bowtie indexes were 520 generated for the combined genome sequence using 'bowtie-build' command. Bowtie 521 alignment was done against the combined genome using parameters: -m 1 -e 70 -k 1 -n 522 2 --best --chunkmbs 200. About 6% of reads aligned to the dm3 genome and ~94% 523 aligned to the hg19 genome. The number of reads aligned to human and Drosophila 524 genome are reported in Table S1 . We identified a union set of 40,222 and 5,716 525
H3K9ac peaks in the human and Drosophila cells respectively. We normalized peak 526 scores for the 40,222 human (hg19) peaks using hg19 aligned read counts (read count 527 normalization) ( Figure S2A ). Moreover, we used Drosophila (dm3) aligned read counts 528 for normalizing peak scores (spike normalization) ( Figure S2B ). Significantly, we 529 observed greater changes in H3K9ac levels on peaks in 3h and 6h insulin treated cells 530 after spike normalization as compared to read count normalization ( Figure S2C and D) . 531
The effect of spike normalization was also evident in aggregate profiles of H3K9ac ±2kb 532 around annotated transcription start sites (TSSs) ( Figure S2E and F) . Overall spike 533 normalization led to better conformity between replicates and revealed global increase 534 in histone acetylation that could be quantified. 535
RNA-seq analyses 536
Total RNA was isolated from insulin treated cells or from tumors tissues using 537
NucleoSpin® RNA kit (Macherey-Nagel, Germany) with on-column DNase I digestion. (Table S2 ). Relative gene expression between groups was determined using 2^-556 DDCt method after normalization with 18S levels. 557
Visualization of ChIP-seq data and additional analyses 558
Reads aligning to the hg19 genome were filtered out from the aligned bam files and 559 peaks were called for each library with respective Input using macs2 (Zhang et al., 560 2008) with broad peak calling option and q < 0.1 for broad regions and q < 0.05 for 561 narrow regions. Peaks were annotated using annotatePeaks.pl command in homer 562 (Heinz et al., 2010) and assigned to the nearest hg19 RefSeq gene TSS. Wiggle tracks 563 were generated using custom scripts, normalized by the number of dm3 aligned reads 564 and visualized on the UCSC Genome Browser. Heatmaps were generated using Java 565
TreeView (Saldanha, 2004) and aggregate profiles were made using deepTools 566 (Ramirez et al., 2016) . Motif enrichment analysis was performed using 567 findMotifsGenome.pl command in homer. 568
Human samples 569
Blood samples were obtained from patients after an 8h fasting period following 570 institutional guidelines at the City of Hope (IRB no. 15418) in purple-top EDTA 571 vacutainer tubes after obtaining written informed consent. Insulin resistance was 572 identified by measuring Hemoglobin A1C (HbA1c) using HPLC method (Davis, 573 McDonald, & Jarett, 1978) . HbA1C levels between 5.7-6.3 were used to define insulin-574 resistance. All individuals were within ages of 18-55. PBMCs were isolated from whole 575 blood using Ficoll-Paque method. Briefly, whole blood was diluted 1:1 with PBS 576 containing 2% FBS, layered on top of 15 ml Ficoll and spun down at 1200´g for 10 577 mins. The white buffy coat containing PBMCs were collected and washed twice with 578 PBS containing 2% FBS and spun down at 1200´g for 10 mins to remove platelets. 0.5 579 ´10 6 PBMCs were lysed in 20 cell volumes of 1X SDS sample buffer and processed for 580 western blot analyses. 581
Tumor xenograft studies 582
Animal studies were performed at the Icahn School of Medicine at Mount Sinai (ISMMS) 583
Center for Comparative Medicine and Surgery. All studies were approved by the ISMMS 584
Institutional Animal Care and Use Committee. All animals used for the studies, were 585 female, on an FVB/n background. The immunodeficient hyperinsulinemic mice were 586 generated as previously described by crossing the recombination-activating gene 1 587 (Rag1) knockout mice with the muscle creatinine kinase promoter expressing dominant-588 negative Igf1r (MKR) mice (Zelenko et al., 2016) . The metabolic phenotyping of the 589 Rag1 knockout (Rag1 -/-) / MKR mice and control Rag1 -/mice has been characterized 590 previously (Zelenko et al., 2016) . Mice for this study were maintained on regular diet 591 (PicoLab Rodent Diet 20, 5053), with free access to water and a 12 hour light / dark 592 cycle. 5´10 6 MDA-MB-231 tumor cells were injected into the inguinal mammary fat pad 593 of Rag1 -/and Rag1 -/-/MKR female mice aged between 8 and 10 weeks. MDA-MB-231 594 tumor growth was measured as previously described (Shlomai et al., 2017) . At the end 595 of the study, tumors were dissected and flash frozen in liquid nitrogen for further 596 analysis. 597
Statistical analyses 598
Data are represented as mean and standard error of mean (Mean + SEM). Statistical 599 analyses were performed using GraphPad Prism 7.0 software (GraphPad Prism 600 Software Inc., San Diego, CA) and R. Normal distribution was confirmed using Shapiro-601
Wilk normality test before performing statistical analyses. For normally distributed data, 602 comparison between two means were assessed by unpaired two-tailed Student's t test 603 and that between three or more groups were evaluated using one-way analysis of 604 variance (ANOVA) followed by Tukey's post hoc test. In case of Student's t-test, F-test 605 was performed to check whether the variance in the groups compared were significantly 606 different. For data where significantly different variances were observed, t-test with 607
Welch correction was performed. For data that did not follow a normal distribution, 608
Mann-Whitney test was performed for comparison between two groups and Kruskal 609
Wallis test followed by Dunn's multiple comparisons test was performed for comparing 610 more than two groups. A p-value of < 0.05 was considered statistically significant. 611 
